Using the UALCAN and Oncomine databases, we proved that the expression of ATAD3A in bladder cancer was higher than that in normal bladder tissue and higher in TP53 mutation than in TP53 nonmutation bearing tumors. This evidence concerns the gene ATAD3A and urinary bladder carcinoma.